Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
IMVARIA Announces Strategic Investments from Leading Healthcare Companies
Company Expands its Ecosystem of Investors with New Financing from InHealth Ventures, Part of a Large UK-Based Health System, and the Labcorp Venture Fund
IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced strategic investments from new and existing investors to accelerate IMVARIA’s growth and fuel innovation in AI-driven digital healthcare. InHealth Ventures (IHV), an early-stage fund linked to leading screening and diagnostics provider InHealth Group, led the funding, with participation from the Labcorp Venture Fund and existing partner Cedar Crest Holdings. The new strategic investments will enable IMVARIA to extend its AI-driven diagnostic services for various forms of lung disease and make IMVARIA’s tests more easily accessible for clinicians, especially pulmonologists.
InHealth Ventures is a London-based early-stage venture capital fund investing in tech-enabled healthcare and life sciences. The firm backs ambitious founders from seed through Series A and beyond, drawing on deep sector expertise and a global network to help companies scale while improving patient outcomes, expanding access, and lowering the cost of care.
Labcorp is a global leader of innovative and comprehensive laboratory services. The company’s Venture Fund invests in and supports early-stage, private companies that are focused on improving health outcomes through innovative offerings aimed at making healthcare more convenient, accessible, data-driven, and personalized.
Cedar Crest Holdings is a biotech investment company that is helping life sciences and biotech companies to drive innovation and improve the human condition.
Led by Stanford School of Medicine-trained practicing physicians who are also trained engineers, formerly of Google, IMVARIA is known for its two FDA authorizations for AI-powered tests, growing commercial traction, a strong interdisciplinary team, and a unique go-to-market strategy for AI tests.
“We share a common mission and vision with our investors to leverage AI in diagnostic testing to make a significantly positive difference in patient care,” said Joshua Reicher, MD, Co-Founder and CEO at IMVARIA…
Full release here, originally announced January 7th, 2026.
Canopy Secures $22M Series B to Define the Standard for Connected Safety and Location Intelligence
Industry Veterans and Luminaries Join Round as Canopy Solidifies Position as the Healthcare Standard for Staff Safety and Location Intelligence
Canopy, the category leader for connected safety platforms in U.S. health systems, today announced the closing of a $22 million Series B funding round. 111° West Capital and ACME Capital led the round, joined by all of Canopy’s existing investors who have watched the company build momentum that is rare in healthcare. The investment backs a critical shift in the market: moving from fragmented point solutions to a single, foundational safety platform that now protects over 300,000 healthcare workers across 60 major U.S. health systems.
The investment, backed by industry veterans behind category-defining companies like Vocera and TigerConnect, arrives as Canopy reaches a critical mass of adoption. The round was oversubscribed, underscoring investor recognition in Canopy’s safety-first architecture as a scalable, category-defining platform.
“From the beginning, we saw safety not just as a workforce issue, but as fundamental to quality care delivery,” said Shan Sinha, Co-Founder and CEO at Canopy. “By building our foundation on safety—the most critical requirement for a high-functioning healthcare environment—we’ve created the Location Intelligence Platform that many leading health systems now rely on. This funding validates that approach and enables us to scale responsibly.”
The adoption of Canopy’s safety platform has delivered measurable results at leading institutions nationwide, affirming the value of an integrated safety platform that spans people, places, and workflows to deliver meaningful protection today, and a long-term foundation health systems can rely on.
“The adoption of Canopy’s technology and platform at Boston Children’s Hospital has been a significant advancement in how we protect our staff,” said Lisa Abbott, CHRO at Boston Children’s Hospital…
Full release here, originally announced January 8th, 2026.
No comments:
Post a Comment